C
Cansativa
Medical cannabis wholesaler and distribution platform
About Cansativa
Cansativa Group is a German company founded in 2017 that specializes in the distribution of medical cannabis. The company operates as a pharmaceutical wholesaler, holding certifications for Good Distribution Practice (GDP) and licenses for handling controlled substances. It has established a business-to-business platform to manage the cannabis value chain, including logistics, and serves a network of thousands of pharmacies across Germany.
A significant aspect of Cansativa's business is its role as the exclusive partner of the German authorities for the distribution of domestically grown cannabis. This partnership underscores the company's position in the German medical cannabis market. In addition to its distribution services, Cansativa provides independent market access for cannabis products and maintains extensive warehousing capabilities.
The company also engages in educational efforts and provides resources for both doctors and patients. For medical professionals, it offers information on treatment options and the process of prescribing cannabis. For patients, it provides guidance on cost coverage, application procedures with health insurance, and the appeals process.
Cansativa's business model is centered on the importation, storage, licensing, and distribution of cannabis products. The company generates revenue through these wholesale and distribution activities, supplying pharmacies with medical cannabis for patients with prescriptions. It also engages in branding and bringing international cannabis products to the German market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Mörfelden-Walldorf, Germany
- Employees
- 65
- Open positions
- None listed
- Dealroom signal
- 82.6/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Wholesale, Pharmacy, Cannabis, Logistics, Tech for Medical Professionals, Frankfurt Forward
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Feb 2022 | $15M | $60M | Casa Verde Capital · Alluti GmbH · Argonautic Ventures | ↗ |
| SERIES A✓Equity / VC | Jun 2021 | $0 | — | Greenfield Global | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Cansativa is 12K monthly website visits, down 7.7% over the last three months. Cansativa's team grew 10.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Northern Swan
Series A4 investors entered at this stage
Greenfield Global
Casa Verde Capital
Alluti GmbH
Argonautic Ventures
Other known investors1 additional known investor
Frankfurt Forward
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cansativa on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cansativa’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.